Clinical trial
Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy…
NCT00311467 · Central European Cooperative Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00311467 |
|---|---|
| Title | Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma |
| Official title | Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma: a Prospective, Randomized, Multi-center phaseIII-Trial |
| Lead sponsor | Central European Cooperative Oncology Group, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Cell Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, Interferon, Interleukin |
| Enrollment | 172 |
| Start date | Mar 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Apr 6, 2006 |
| Last update posted | May 16, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: